Shares of MakeMyTrip saw 1,326,976 shares change hands during Wednesday’s session, marking a 41% increase from the prior day’s volume of 941,092 shares. This uptick followed the company’s announcement of quarterly earnings of $0.52 per share, surpassing the consensus estimate of $0.43. While revenue for the period came in at $295.70 million—below analysts’ expectation of $306.29 million—the strong EPS performance drove heightened market activity and investor interest.

MakeMyTrip reported a return on equity of 35.84% and a net margin of 5.46%, underscoring efficient cost management and healthy profitability. On the balance sheet, the company maintains a debt-to-equity ratio of 38.85 and both current and quick ratios of 1.91, indicating ample liquidity to cover short-term obligations. With a market capitalization of $7.38 billion and a beta of 0.66, the firm balances growth potential with moderate volatility relative to the broader market.

Wall Street’s view remains largely positive: Bank of America recently adjusted its target from $115 to $113 while maintaining a Buy rating, Morgan Stanley reaffirmed an Overweight stance, and Citigroup set a $96 target with a Buy designation. Weiss Ratings initiated coverage with a Hold (c) recommendation, and one boutique firm downgraded to Sell. Among five active analysts, four recommend buying the shares and one rates them as Hold, yielding a consensus price target of $106.33.

Institutional investors now hold 51.89% of MakeMyTrip’s stock. Federated Hermes increased its position by 2,438.5% in the second quarter, adding 146,968 shares to reach 152,995 shares valued at $15.0 million. Nomura Asset Management established a new stake worth $30.0 million, while Seven Grand Managers and Helios Capital built new positions of $7.35 million and $2.57 million, respectively. Schroder Investment Management boosted its holdings by 42.4%, acquiring an additional 1.67 million shares for a total stake valued at $551.7 million.